RH director Mark Demilio sold 2,254 shares of company stock in a single transaction on January 14, realizing proceeds of $495,880. Following the sale, Demilio’s direct ownership declined by 10.15%, leaving him with 19,962 shares valued at approximately $4.39 million. The sale was disclosed in an SEC filing, marking the latest in a series of insider transactions that some investors interpret as a signal of tempered confidence in the near-term outlook.

In its December quarter, RH reported revenue of $883.8 million, up 8.9% year-over-year and essentially in line with consensus estimates. Earnings per share came in at $1.71, missing analyst forecasts of $2.13, as net margin contracted to 3.22% and return on equity stayed deeply negative at 161.7%. The company’s leverage remains elevated, with a debt-to-equity ratio exceeding 900%, underscoring the need for margin improvement to support future earnings growth.

Analyst opinions on RH diverge sharply. Morgan Stanley upgraded RH with a material upside in its near-term forecast, citing intact revenue growth and the potential for a multiple re-rating as top-line momentum continues. Conversely, Goldman Sachs downgraded the stock to a sell rating after lowering its forecast, pointing to persistent margin weakness and high leverage as key headwinds. Overall, nine analysts maintain a buy rating, eight a hold, and four a sell, resulting in a consensus ‘‘hold’’ stance as investors weigh growth prospects against fundamental challenges.